Tetrapyrroles and derivatives
Abcam SB 243213 dihydrochloride, 5HT2C receptor antagonist, 50MG
MW 464.9 Da, Purity >99%. Potent, selective 5-HT2C receptor antagonist (Ki = 1 nM). Neurological agent. Active *in vivo* and *in vitro*.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Bisindolylmaleimide II, PKC inhibitor, 1MG
MW 438.5 Da, Purity >97%. Potent, selective ATP-competitive PKC inhibitor (IC₅₀ values are 0.01, 0.75 and 2 μM for PKC, phosphorylase kinase and PKA respectively). Potent noncompetitive nAChR antagonist (IC₅₀ = 0.03 μM, catecholamine secretion in nicotine-stimulated PC-12 cells). Shows more potent antinicotinic effects than Bisindolylmaleimide IV (ab144208) and V (ab144205). Induces apoptosis and shows antiproliferative effects.
The product is subject to the following: Abcam Restricted Use Statement
Abcam (±)-Miconazole nitrate, Imidazole antifungal agent, 1G
MW 479.1 Da, Purity >99%. Imidazole antifungal agent. Inhibits fungal membrane ergosterol biosynthesis. Increases reactive oxygen species production.
The product is subject to the following: Abcam Restricted Use Statement
Abcam SB 408124, non-peptide O x 1 antagonist, 10MG
MW 356.4 Da, Purity >97%. Selective, non-peptide orexin receptor 1 (OX1) antagonist (Ki = 26.9 nM). Displays 50-fold selectivity over OX2 (Kb values are 21.7 and 1405 nM for OX1 and OX2, respectively).
The product is subject to the following: Abcam Restricted Use Statement
Abcam Genipin, Cell-permeable uncoupling protein 2 inhibitor, 100MG
MW 226.23 g/mol, Purity >99%. Cell-permeable uncoupling protein 2 (UCP2) inhibitor. Anti-inflammatory, anti-angiogenic and pro-apototic effects. Acts as a protein cross-linker.
The product is subject to the following: Abcam Restricted Use Statement
Abcam HTMT (Histamine trifluoromethyl toluidide) dimaleate, H1/H2 receptor agonist, 10MG
MW 628.6 Da, Purity >99%. H1/H2 receptor agonist (Ki = 1.2 µM). More potent than histamine (ab120734). Activates IP3/Ca2+ signaling and induces proliferation of small cholangiocytes. Active *in vivo*.
The product is subject to the following: Abcam Restricted Use Statement
Strem, An Ascensus Company CAS# 574-93-6. 5g. Phthalocyanine. MFCD00005085
CAS# 574-93-6. 5g. Phthalocyanine. MFCD00005085. Molecular Weight: 514.55. Molecular Formula: C32H18N8. Color/form: blue black pwdr. Strem# 07-1700. http://www.strem.com/catalog/v/07-1700/
Abcam QNZ, NF-kB inhibitor, 1MG
MW 358.4 Da, Purity >98%. Potent, selective NF-kB inhibitor (IC₅₀ = 11 nM). Inhibits LPS-induced TNFα production (IC₅₀ = 7 nM). Reduces edema in inflammation in vivo..
The product is subject to the following: Abcam Restricted Use Statement
Sigma Aldrich Fine Chemicals Biosciences Cytochrome c from equine heart | 9007-43-6 | MFCD00130890 | 100mg
Cytochrome c from equine heart | 95%MW: | 9007-43-6 | MFCD00130890 | 100mg
Sigma Aldrich Fine Chemicals Biosciences Cytochrome c from equine heart | 9007-43-6 | MFCD00130890 | 250mg
Cytochrome c from equine heart | Purity: ≥95% | Mol Wt: 12384 | 9007-43-6 | MFCD00130890 | 250mg
Sigma Aldrich Fine Chemicals Biosciences 5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine Dye content 95 % | 51094-17-8 | MFCD00191501 | 1G
5,10,15,20-Tetrakis(4-hydroxyphenyl)-21H,23H-porphine Dye content 95 % | Mol Wt: 678.73 | 51094-17-8 | MFCD00191501 | 1G
Cayman Chemical Vitamin B12, Purity: ≥95%, CAS: 68-19-9, 5 g
A corrinoid vitamin with roles in brain and nervous system functioning and blood formation through regulation of DNA synthesis, cellular metabolism, fatty acid metabolism, and amino acid metabolism; serves as a cofactor in isomerase-, methyltransferase-, and dehalogenase-catalyzed reactions, including the conversion of methylmalonyl-CoA to succinyl-CoA and the transfer of a methyl group from 5-methyltetrahydrofolate to homocysteine
Abcam Kynurenic acid sodium salt, Endogenous ionotropic / nicotinic antagonist, 1G
MW 211.15 Da, Purity >99%. Endogenous antagonist at ionotropic, glycine and α7 nicotinic receptors. Neuroprotective in vivo. Soluble in 1 ml water to give specified mM/ml concentration. Find out more.
The product is subject to the following: Abcam Restricted Use Statement
Abcam Dihydrokainic acid, EAAT2 (GLT-1) inhibitor, 10MG
MW 215.25 Da. Selective, non-transportable inhibitor of glutamate transporter EAAT2 (GLT-1) (Ki = 23 μM). 130-fold selective over EAAT1 and EAAT3 (Ki > 3 mM).
The product is subject to the following: Abcam Restricted Use Statement
Abcam beta-Amyloid Peptide (42-1) (human), Inactive control, 1MG
MW 4514 Da. beta-Amyloid Peptide (42-1) (human), Inactive control. Achieve your results faster with highly validated, pure and trusted compounds.
The product is subject to the following: Abcam Restricted Use Statement